Study in Participants With Acute Migraines Headaches

Exclusion Criteria

• •Participants who do not or may not tolerate 5HT1 agonist treatments, with known hypersensitivity to sumatriptan (as discussed with the investigator).
• •Female participants who have a positive pregnancy test at screening or pre- dose evaluation, or are breastfeeding.
• •History or presence of significant medical illnesses as determined by the investigator.
• •Participants with a current clinical diagnosis of major psychiatric disease.
• •Regular use of known drugs of abuse; use of opiates for migraine rescue (no more than two times per month) is permissible.
• •Blood donation of 500 milliliter (mL) or greater of whole blood products within 4 weeks of study commencement, during the study, or 4 weeks following the study.
• •Investigator site personnel directly affiliated with this study and their immediate families. Immediate family is defined as a spouse, parent, child, or sibling, whether biological or legally adopted.
• •Consumption of more than three units of alcohol per day where one unit is defined as a 12 ounces (oz) beer, 4 oz wine, or 2 oz of alcohol spirit liquor.
• •Are unwilling or unable to comply with the use of a diary to directly record data from the participant.